Literature DB >> 28106928

Diagnostic considerations for cholestatic liver disease.

Galia Pollock1, Gerald Y Minuk1.   

Abstract

Cholestatic liver disease results from insufficient bile synthesis, secretion and/or flow through the biliary tract. Common presenting features include fatigue, pruritus, and cholestatic liver enzyme abnormalities wherein elevations of serum alkaline phosphatase and gamma-glutamyltransferases levels exceed those of alanine and aspartate aminotransferases. With prolonged cholestasis, fat soluble vitamin deficiencies, fibrosis, cirrhosis, and, on occasion, carcinoma of the biliary tract or liver can occur. Once mechanical obstruction to bile flow has been ruled out, the majority of causes can be classified as immune-mediated, infectious, or miscellaneous. Because specific therapeutic options are increasing for many causes of cholestasis, an accurate diagnosis is an important first step towards treatment. Thus, this review focuses on the diagnostic features of non-mechanical causes of cholestasis.
© 2017 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  cholangitis; cholestasis; granulomatous liver disease; liver disease; primary biliary cirrhosis; primary sclerosing cholangitis

Mesh:

Year:  2017        PMID: 28106928     DOI: 10.1111/jgh.13738

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  9 in total

Review 1.  Animal models of biliary injury and altered bile acid metabolism.

Authors:  Valeria Mariotti; Mario Strazzabosco; Luca Fabris; Diego F Calvisi
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-07-11       Impact factor: 5.187

Review 2.  Primary sclerosing cholangitis: diagnostic and management challenges.

Authors:  Sanjeev Sirpal; Natasha Chandok
Journal:  Clin Exp Gastroenterol       Date:  2017-11-06

3.  Integrating Network Analysis and Metabolomics to Reveal Mechanism of Huaganjian Decoction in Treatment of Cholestatic Hepatic Injury.

Authors:  Qin Dong; Jiao Chen; Yan-Ping Jiang; Zong-Ping Zhu; Yong-Feng Zheng; Jin-Ming Zhang; Zhen Zhang; Wen-Qing Chen; Shi-Yi Sun; Lan Pang; Xin Yan; Wan Liao; Chao-Mei Fu
Journal:  Front Pharmacol       Date:  2022-01-19       Impact factor: 5.810

Review 4.  Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts.

Authors:  Ralf Weiskirchen; Sabine Weiskirchen; Frank Tacke
Journal:  F1000Res       Date:  2018-06-27

5.  Identification of potential biomarkers in cholestasis and the therapeutic effect of melatonin by metabolomics, multivariate data and pathway analyses.

Authors:  Han Yu; Yunzhou Li; Zongying Xu; Dingnan Wang; Shaohua Shi; Huifang Deng; Baihui Zeng; Zhili Zheng; Lili Sun; Xiulan Deng; Xianggen Zhong
Journal:  Int J Mol Med       Date:  2018-09-05       Impact factor: 4.101

6.  Three-dimensional spatially resolved geometrical and functional models of human liver tissue reveal new aspects of NAFLD progression.

Authors:  Fabián Segovia-Miranda; Hernán Morales-Navarrete; Michael Kücken; Vincent Moser; Sarah Seifert; Urska Repnik; Fabian Rost; Mario Brosch; Alexander Hendricks; Sebastian Hinz; Christoph Röcken; Dieter Lütjohann; Yannis Kalaidzidis; Clemens Schafmayer; Lutz Brusch; Jochen Hampe; Marino Zerial
Journal:  Nat Med       Date:  2019-12-02       Impact factor: 53.440

7.  Mechanism of Paeoniflorin in the Treatment of Bile Duct Ligation-Induced Cholestatic Liver Injury Using Integrated Metabolomics and Network Pharmacology.

Authors:  Shizhang Wei; Xiao Ma; Ming Niu; Ruilin Wang; Tao Yang; Dan Wang; Jianxia Wen; Haotian Li; Yanling Zhao
Journal:  Front Pharmacol       Date:  2020-10-20       Impact factor: 5.810

8.  Effect of nalfurafine hydrochloride in patients with chronic liver disease with refractory pruritus on sleep disorders: a study protocol for single-arm, prospective, interventional study.

Authors:  Kazunori Yoh; Hiroki Nishikawa; Hirayuki Enomoto; Yoshinori Iwata; Akio Ishii; Yukihisa Yuri; Noriko Ishii; Yuho Miyamoto; Kunihiro Hasegawa; Chikage Nakano; Ryo Takata; Takashi Nishimura; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Hiroko Iijima; Shuhei Nishiguchi
Journal:  BMJ Open Gastroenterol       Date:  2017-09-29

9.  A Model Incorporating Serum Alkaline Phosphatase for Prediction of Liver Fibrosis in Adults with Obesity and Nonalcoholic Fatty Liver Disease.

Authors:  Ahmad Hassan Ali; Gregory F Petroski; Alberto A Diaz-Arias; Alhareth Al Juboori; Andrew A Wheeler; Rama R Ganga; James B Pitt; Nicole M Spencer; Ghassan M Hammoud; R Scott Rector; Elizabeth J Parks; Jamal A Ibdah
Journal:  J Clin Med       Date:  2021-07-27       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.